Fresenius Escapes $25 Million Damages Award, Based on Invalidation of Baxter Patent In Ex Parte Reexamination

Publication Date09 July 2013
Law FirmFoley & Lardner LLP
SubjectInter Partes Reexamination,Litigation Strategies,Patent Litigation,Patents,USPTO

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT